Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MCHM transdermal gel drug delivery -- Ignore unavailable to you. Want to Upgrade?

To: AlienTech who wrote (374)	5/6/1998 8:56:00 AM
From: Richard Singer	Respond to of 419

AT- I also have a small position in VVUS, and enjoyed the largest profits of my last two years on the stock of that company. The WSJ article took me out of my MCHM at 11 3/4 yesterday, but only temporarily. I don't believe there was much substance to the article, but I wanted to protect a good profit. IMHO Macrochem will soon begin to prosper from licencing their SEPA technology to those majors with whom they now associate, as well as others. This is a pure R&D play with a lot of eyes turning their way. Good luck, Richard